AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28109092 — intervention group
Group type: COMPARATOR
Intervention: No preoperative mechanical bowel preparation
Number of subjects: 148
Study 26231302 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealing
Number of subjects: 26
Study 26231302 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement
Number of subjects: 26
Study 26231302 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 26
Study 23059373 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine 5'-monophosphate (AMP) challenge
Number of subjects: 18
Study 23059373 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine challenge
Number of subjects: 18
Study 22093197 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonemergency PCI at non-SOS hospitals
Number of subjects: 3690
Study 22093197 — intervention group
Group type: COMPARATOR
Intervention: Nonemergency PCI at SOS hospitals
Number of subjects: 3690
Study 19228431 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate and booster 23-valent polysaccharide vaccine
Number of subjects: 148
Study 19228431 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no vaccination)
Number of subjects: 148
Study 16511715 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% isotonic solution of sodium carboxymethylcellulose (CMC)
Number of subjects: 19
Study 16511715 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (control)
Number of subjects: 19
Study 12975626 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulation
Number of subjects: 28
Study 12975626 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription medications
Number of subjects: 28
Study 12975626 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care education
Number of subjects: 28
Study 10731269 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary nicardipine (200 mcg)
Number of subjects: 9
Study 10731269 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary diltiazem (1 mg)
Number of subjects: 9
Study 10731269 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary verapamil (200 mcg)
Number of subjects: 9
Study 8617088 — intervention group
Group type: EXPERIMENTAL
Intervention: Wire-guided catheters (WGC)
Number of subjects: 67
Study 8617088 — intervention group
Group type: COMPARATOR
Intervention: Non-wire-guided catheters (non-WGC)
Number of subjects: 67
Study 1472184 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant psychological therapy
Number of subjects: 174
Study 1472184 — intervention group
Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 174
Study 6363397 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxapine
Number of subjects: 0
Study 6363397 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study 31259608 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide 125 mg twice daily, day of ascent dosing
Number of subjects: 104
Study 31259608 — intervention group
Group type: COMPARATOR
Intervention: Acetazolamide 125 mg twice daily, night before dosing
Number of subjects: 104
Study 29723022 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported education services delivered by veteran peers
Number of subjects: 33
Study 29723022 — intervention group
Group type: COMPARATOR
Intervention: Matched attention of generalized support without supporting educational goals (Control)
Number of subjects: 33
Study 26811067 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary microsurgical repair of the injured nerve with the additional use of a chitosan nerve tube
Number of subjects: 100
Study 26811067 — intervention group
Group type: COMPARATOR
Intervention: Direct tension free microsurgical repair of the injured nerve alone
Number of subjects: 100
Study 24512643 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA testing restricted to younger men (age cut-offs of 60, 65, and 70)
Number of subjects: 3936
Study 24512643 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA levels below 1 ng/ml
Number of subjects: 3936
Study 21898012 — intervention group
Group type: EXPERIMENTAL
Intervention: Floppy Nissen fundoplication (group I, n = 50)
Number of subjects: 100
Study 21898012 — intervention group
Group type: EXPERIMENTAL
Intervention: Toupet fundoplication (group II, n = 50)
Number of subjects: 100
Study 19147527 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 1.5 mg/kg once daily
Number of subjects: 120
Study 19147527 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin 1 mg/kg twice daily (Control)
Number of subjects: 120
Study 17592287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Sequential Pneumatic Compression (ISPC) device during pneumoperitoneum (PP)
Number of subjects: 20
Study 17592287 — intervention group
Group type: COMPARATOR
Intervention: Control group without ISPC
Number of subjects: 20
Study 16146494 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-beta-1a 44 microg subcutaneous three times weekly (t.i.w.) for 12 months
Number of subjects: 21
Study 16146494 — intervention group
Group type: COMPARATOR
Intervention: Post-treatment follow-up without IFN-beta-1a
Number of subjects: 21
Study 16146494 — intervention group
Group type: EXPERIMENTAL
Intervention: During treatment and follow-up
Number of subjects: 21
Study 11890233 — intervention group
Group type: EXPERIMENTAL
Intervention: Urological trainees
Number of subjects: 122
Study 11890233 — intervention group
Group type: COMPARATOR
Intervention: Consultants
Number of subjects: 122
Study 11890233 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 122
Study 9784675 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment with low‐molecular‐weight heparin
Number of subjects: 28
Study 9784675 — intervention group
Group type: COMPARATOR
Intervention: In-hospital treatment with unfractionated heparin
Number of subjects: 28
Study 9784675 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 28
Study 7840824 — intervention group
Group type: COMPARATOR
Intervention: 0 mg i.v. of murine anti EGF‐R IgG2a mab EMD 55900
Number of subjects: 16
Study 7840824 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg i.v. of murine anti EGF‐R IgG2a mab EMD 55900
Number of subjects: 16
Study 7840824 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg i.v. of murine anti EGF‐R IgG2a mab EMD 55900
Number of subjects: 16
Study 7840824 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg i.v. of murine anti EGF‐R IgG2a mab EMD 55900
Number of subjects: 16
Study 3340118 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 weeks of chemohormonal therapy (cyclophosphamide, methotrexate, fluorouracil, vincristine, prednisone, doxorubicin, tamoxifen)
Number of subjects: 205
Study 3340118 — intervention group
Group type: COMPARATOR
Intervention: 36 weeks of chemotherapy (cyclophosphamide, methotrexate, fluorouracil, vincristine, prednisone)
Number of subjects: 205
Study 31770007 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exergame training (11‐13 perceived exertion)
Number of subjects: 20
Study 31770007 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous exergame training (14‐16 perceived exertion)
Number of subjects: 20
Study 30458880 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative resuscitation strategies
Number of subjects: 207
Study 30458880 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcirculatory perfusion parameters
Number of subjects: 207
Study 30458880 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcirculatory perfusion
Number of subjects: 207
Study 27575584 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole‐body cold mist shower therapy
Number of subjects: 121
Study 25611597 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized physiotherapy protocol (EG)
Number of subjects: 16
Study 25611597 — intervention group
Group type: COMPARATOR
Intervention: Typical, non‐standardized physiotherapy treatment (CG)
Number of subjects: 16
Study 23413448 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical appraisal education program (1-day, small group discussion)
Number of subjects: 0
Study 20832867 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 lux light condition
Number of subjects: 23
Study 20832867 — intervention group
Group type: COMPARATOR
Intervention: 10,000 lux light condition
Number of subjects: 23
Study 20832867 — intervention group
Group type: COMPARATOR
Intervention: 100 lux light condition
Number of subjects: 23
Study 18680695 — intervention group
Group type: EXPERIMENTAL
Intervention: Screened for HLA‐B*5701 before starting abacavir treatment
Number of subjects: 1956
Study 18680695 — intervention group
Group type: COMPARATOR
Intervention: Conventional follow-up (Control)
Number of subjects: 1956
Study 18680695 — intervention group
Group type: EXPERIMENTAL
Intervention: Epicutaneous patch testing for immunological confirmation
Number of subjects: 1956
Study 17154749 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-based treatments
Number of subjects: 53
Study 17154749 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in probability bias
Number of subjects: 53
Study 17154749 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in cost bias
Number of subjects: 53
Study 12671943 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2-Hz repetitive transcranial magnetic stimulation (rTMS) over Cz (motor cortical stimulation)
Number of subjects: 85
Study 12671943 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2-Hz repetitive transcranial magnetic stimulation (rTMS) over inion (occipital stimulation)
Number of subjects: 85
Study 12671943 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 85
Study 10557020 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg daily for 12 weeks
Number of subjects: 19
Study 10557020 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 19
Study 10557020 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg daily
Number of subjects: 19
Study 10557020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 10557020 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg daily and Placebo
Number of subjects: 19
Study 8533749 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass treatment and behavior modification campaign
Number of subjects: 1417
Study 8533749 — intervention group
Group type: EXPERIMENTAL
Intervention: Female children
Number of subjects: 1417
Study 8533749 — intervention group
Group type: EXPERIMENTAL
Intervention: Familial cattle ownership and having one or more siblings with trachoma at baseline
Number of subjects: 1417
Study 8533749 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustainably clean face
Number of subjects: 1417
Study 8533749 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved face-washing plus antibiotic treatment
Number of subjects: 1417
Study 1882473 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Level Laser therapy (Galium‐Aluminium‐Arsenide laser, 30 mW/830 nm, Unilaser 2000 3B)
Number of subjects: 60
Study 1882473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 6350479 — intervention group
Group type: EXPERIMENTAL
Intervention: Etretinate
Number of subjects: 20
Study 6350479 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study 31514977 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure using ear pellets on 5 acupoints for 8 weeks
Number of subjects: 65
Study 31514977 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 65
Study 29075780 — intervention group
Group type: EXPERIMENTAL
Intervention: irinotecan plus panitumumab (IrPan)
Number of subjects: 308
Study 29075780 — intervention group
Group type: COMPARATOR
Intervention: irinotecan
Number of subjects: 308
Study 29075780 — intervention group
Group type: EXPERIMENTAL
Intervention: HER3-high, AREG/EREG-high tumors with panitumumab
Number of subjects: 308
Study 29075780 — intervention group
Group type: COMPARATOR
Intervention: HER3-low, AREG/EREG-low tumors
Number of subjects: 308
Study 28116431 — intervention group
Group type: EXPERIMENTAL
Intervention: Koukuining granules, taken orally after a meal, 3 times a day, 1 bag each time, for 10 days, repeated after 3 days of interval.
Number of subjects: 100
Study 28116431 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C and compound vitamin B2, taken orally for 2 courses.
Number of subjects: 100
Study 25060415 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure (BP) <110/60 mm Hg
Number of subjects: 3947
Study 25060415 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal blood pressure target of 140/78 mm Hg
Number of subjects: 3947
Study 25060415 — intervention group
Group type: EXPERIMENTAL
Intervention: U-shaped relation between BP and ACM
Number of subjects: 3947
Study 23204609 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended bedtime (10 hr) for 4 nights (EXT)
Number of subjects: 18
Study 23204609 — intervention group
Group type: COMPARATOR
Intervention: Habitual bedtimes (HAB) for 4 nights
Number of subjects: 18
Study 20685507 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (generic glimepiride 2 mg)
Number of subjects: 23
Study 20685507 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (branded glimepiride 2 mg)
Number of subjects: 23
Study 18714738 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment consisting of a 7-day administration of one proton pump inhibitor and 2 out of 3 antibiotics (amoxicillin, clarithromycin, metronidazole)
Number of subjects: 0
Study 18714738 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple treatment regimen consisting of bismuth salts, tetracycline, metronidazole, and proton pump inhibitor
Number of subjects: 0
Study 18714738 — intervention group
Group type: EXPERIMENTAL
Intervention: New antibiotics (levofloxacin and rifabutin) for Hp eradication
Number of subjects: 0
Study 18714738 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication treatment assessed with urease or breath test
Number of subjects: 0
Study 18714738 — intervention group
Group type: EXPERIMENTAL
Intervention: Active search for Hp infection in asymptomatic population
Number of subjects: 0
Study 15929666 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroidectomies without searching for the EBSLN (G1)
Number of subjects: 100
Study 15929666 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroidectomies searching for the EBSLN (G2)
Number of subjects: 100
Study 15929666 — intervention group
Group type: COMPARATOR
Intervention: Control group (G3)
Number of subjects: 100
Study 12870120 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-cycle structured intermittent therapy (SIT; 4 weeks without HAART followed by 8 weeks with HAART)
Number of subjects: 41
Study 12870120 — intervention group
Group type: COMPARATOR
Intervention: Continuous highly active antiretroviral therapy (HAART)
Number of subjects: 41
Study 10604411 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricopharyngeal myotomy and tracheal cartilaginous implantation
Number of subjects: 21
Study 10604411 — intervention group
Group type: COMPARATOR
Intervention: Control (no surgical intervention)
Number of subjects: 21
Study 7560477 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Negative External Pressure (CNEP)
Number of subjects: 15
Study 7560477 — intervention group
Group type: COMPARATOR
Intervention: Positive End-Expiratory Pressure (PEEP) 10 cmH2O
Number of subjects: 15
Study 7560477 — intervention group
Group type: COMPARATOR
Intervention: Zero End-Expiratory Pressure (ZEEP)
Number of subjects: 15
Study 1777297 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety management booklet
Number of subjects: 0
Study 1777297 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment from general practitioner
Number of subjects: 0
Study 7048668 — intervention group
Group type: EXPERIMENTAL
Intervention: DEC (diethylcarbamazine) given in spaced doses (once weekly, monthly, or bi-monthly)
Number of subjects: 78
Study 7048668 — intervention group
Group type: EXPERIMENTAL
Intervention: DEC (diethylcarbamazine) at a total dose of 36-48 mg/kg
Number of subjects: 78
Study 7048668 — intervention group
Group type: EXPERIMENTAL
Intervention: DEC (diethylcarbamazine) at a total dose of 72 mg/kg
Number of subjects: 78
Study 7048668 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole (3 mg/kg) prior to DEC (6 mg/kg/day for 7 days)
Number of subjects: 78
Study 7048668 — intervention group
Group type: EXPERIMENTAL
Intervention: Retreatment with DEC (6 mg/kg/day for 7 days)
Number of subjects: 78
Study 6437366 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 267
Study 6437366 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 267
Study 6437366 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate and imipramine combination
Number of subjects: 267
Study 6437366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 30566708 — intervention group
Group type: EXPERIMENTAL
Intervention: Large spot laser
Number of subjects: 40
Study 30566708 — intervention group
Group type: COMPARATOR
Intervention: Standard spot laser
Number of subjects: 40
Study 26546298 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic local anesthetic intrauterine cornual block (ICOB) plus direct local anesthetic cervical block (DCB) using 1 mL 3% mepivacaine plus 1 mL 0.5% bupivacaine
Number of subjects: 0
Study 26546298 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving DCB plus ICOB with 2 mL of placebo (saline)
Number of subjects: 0
Study 23465084 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate doses of lithium plus optimized treatment (OPT)
Number of subjects: 264
Study 23465084 — intervention group
Group type: COMPARATOR
Intervention: Optimized treatment (OPT) alone
Number of subjects: 264
Study 22154548 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured pre-operative interview conducted by operating room nurses
Number of subjects: 335
Study 22154548 — intervention group
Group type: COMPARATOR
Intervention: Current situation without any formal intervention (control group)
Number of subjects: 335
Study 20626016 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-targeted intervention involving massage and humor therapy
Number of subjects: 178
Study 20626016 — intervention group
Group type: EXPERIMENTAL
Intervention: Identical child intervention plus a parent intervention involving massage and relaxation/imagery
Number of subjects: 178
Study 20626016 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 178
Study 20626016 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 178
Study 17597711 — intervention group
Group type: EXPERIMENTAL
Intervention: GI181771X (selective CCK‐A agonist)
Number of subjects: 701
Study 17597711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 701
Study 16372905 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV+)
Number of subjects: 24
Study 16372905 — intervention group
Group type: COMPARATOR
Intervention: Control (only static exercise)
Number of subjects: 24
Study 12218519 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine pretraumatic injection
Number of subjects: 17
Study 12218519 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine posttraumatic injection
Number of subjects: 17
Study 12218519 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo) pretraumatic injection
Number of subjects: 17
Study 12218519 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo) posttraumatic injection
Number of subjects: 17
Study 11783195 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvia injection (SI)
Number of subjects: 90
Study 11783195 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 90
Study 11783195 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated traditional Chinese and western medicine (TCM‐WM)
Number of subjects: 90
Study 8684533 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid treatment for an average period of 18 months
Number of subjects: 46
Study 8684533 — intervention group
Group type: COMPARATOR
Intervention: No steroid treatment
Number of subjects: 46
Study 1933182 — intervention group
Group type: EXPERIMENTAL
Intervention: J pouch
Number of subjects: 61
Study 1933182 — intervention group
Group type: EXPERIMENTAL
Intervention: S pouch
Number of subjects: 61
Study 1933182 — intervention group
Group type: EXPERIMENTAL
Intervention: W pouch
Number of subjects: 61
Study 1933182 — intervention group
Group type: COMPARATOR
Intervention: Mucosal proctectomy
Number of subjects: 61
Study 1933182 — intervention group
Group type: EXPERIMENTAL
Intervention: J and W pouches
Number of subjects: 61
Study 1933182 — intervention group
Group type: EXPERIMENTAL
Intervention: Pouchitis
Number of subjects: 61
Study 1933182 — intervention group
Group type: EXPERIMENTAL
Intervention: Pouch evacuation
Number of subjects: 61
Study 6295861 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg Ranitidine at night
Number of subjects: 78
Study 6295861 — intervention group
Group type: COMPARATOR
Intervention: Low-dose antacid when necessary
Number of subjects: 78
Study 30248040 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise program taught by physiotherapist
Number of subjects: 80
Study 30248040 — intervention group
Group type: COMPARATOR
Intervention: Home exercise program (brochure provided by orthopedist)
Number of subjects: 80
Study 27398918 — intervention group
Group type: EXPERIMENTAL
Intervention: GAA 15 training program (15 minutes of neuromuscular training exercises, twice weekly for 8 weeks)
Number of subjects: 78
Study 27398918 — intervention group
Group type: EXPERIMENTAL
Intervention: GAA 15 training program
Number of subjects: 78
Study 27398918 — intervention group
Group type: COMPARATOR
Intervention: Usual team training (control)
Number of subjects: 78
Study 25375311 — intervention group
Group type: EXPERIMENTAL
Intervention: SPI-guided analgesia
Number of subjects: 100
Study 25375311 — intervention group
Group type: COMPARATOR
Intervention: Standard analgesia
Number of subjects: 100
Study 25375311 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 23999980 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care management plus TENS (transcutaneous electrical nerve stimulation) used once a day for 45 minutes over six weeks
Number of subjects: 241